-
- Topic
- Voices
- Last Post
-
-
BRAF/MEK inhibitors and statins
Started by:
in: Side-effect management
- 3
- December 14, 2017 at 4:47 pm
-
Frequency of visits on ipi + nivo
Started by:
- 4
- November 19, 2017 at 10:59 pm
-
VIvid dreams
Started by:
- 3
- November 15, 2017 at 8:29 pm
-
Teeth issues on immunoRx
Started by:
- 4
- November 12, 2017 at 4:01 pm
-
Targeted therapies for adjuvant therapy
Started by:
- 2
- November 3, 2017 at 2:07 am
-
Finacial toxicity
Started by:
- 2
- November 3, 2017 at 1:32 am
-
antibiotic ppy when on steroids
Started by:
- 2
- November 2, 2017 at 12:00 am
-
Adjuvant therapy
Started by:
- 2
- November 1, 2017 at 10:15 pm
-
Hepatitis after colitis
Started by:
- 1
- November 1, 2017 at 7:21 pm
-
Ipilimumab infusion reaction
Started by:
- 1
- November 1, 2017 at 6:49 pm
-
Lesion oozing
Started by:
in: Infectious Precautions
- 2
- October 3, 2017 at 7:04 pm
-
Patient Counselling
Started by:
- 2
- October 3, 2017 at 7:03 pm
-
Standard Doses – pembrolizumab
Started by:
- 2
- October 3, 2017 at 7:03 pm
-
pembrolizumab
Started by:
- 2
- October 3, 2017 at 7:02 pm
-
nivolumab
Started by:
- 2
- October 3, 2017 at 6:55 pm
-
BRAF/MEK inhibitors and statins
Copyright ©2023- - The Melanoma Nursing Initiative. All rights reserved.